Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Nasser Alkhushaym, Abdulaali R. Almutairi, Abdulhamid Althagafi, Saad B. Fallatah, Mok Oh, Jennifer R. Martin, Hani M. Babiker, Ali McBride & Ivo Abraham. (2020) Exposure to proton pump inhibitors and risk of pancreatic cancer: a meta-analysis. Expert Opinion on Drug Safety 19:3, pages 327-334.
Read now
Read now
Articles from other publishers (22)
Rehan Rais, Nikolaos A. Trikalinos, Jingxia Liu & Deyali Chatterjee. (2021) Enterochromaffin-like Cell Hyperplasia–Associated Gastric Neuroendocrine Tumors May Arise in the Setting of Proton Pump Inhibitor Use. Archives of Pathology & Laboratory Medicine 146:3, pages 366-371.
Crossref
Crossref
Davide Ravizza & Giancarla Fiori. 2021. Neuroendocrine Neoplasia Management. Neuroendocrine Neoplasia Management
179
190
.
Lingaku Lee, Irene Ramos-Alvarez, Tetsuhide Ito & Robert T. Jensen. (2019) Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome. International Journal of Molecular Sciences 20:20, pages 5128.
Crossref
Crossref
Simona Grozinsky-Glasberg, Krystallenia I. Alexandraki, Anna Angelousi, Eleftherios Chatzellis, Stavros Sougioultzis & Gregory Kaltsas. (2018) Gastric Carcinoids. Endocrinology and Metabolism Clinics of North America 47:3, pages 645-660.
Crossref
Crossref
Malcolm D. Kearns, Ben Boursi & Yu-Xiao Yang. (2017) Proton pump inhibitors on pancreatic cancer risk and survival. Cancer Epidemiology 46, pages 80-84.
Crossref
Crossref
C. S. Jianu, R. Fossmark, T. Viset, G. Qvigstad, Ø. Sørdal, R. Mårvik & H. L. Waldum. (2012) Gastric carcinoids after long‐term use of a proton pump inhibitor. Alimentary Pharmacology & Therapeutics 36:7, pages 644-649.
Crossref
Crossref
. 2011. Rosai and Ackerman's Surgical Pathology. Rosai and Ackerman's Surgical Pathology
585
816
.
Daisuke KUGA, Masatoshi ISOGAI, Toru HARADA, Yuji KANEOKA, Atsuyuki MAEDA & Yu TAKAHASHI. (2010) A CASE OF MULTIPLE ENDOCRINE NEOPLASIA TYPE 1 PRESENTED WITH LIVER METASTASIS. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 71:12, pages 3045-3053.
Crossref
Crossref
Shih-Fan Kuan. 2010. Molecular Pathology of Endocrine Diseases. Molecular Pathology of Endocrine Diseases
247
257
.
DAVID LEWIN & KLAUS J. LEWIN. 2009. Modern Surgical Pathology. Modern Surgical Pathology
673
718
.
Marc J. Berna, Bruno Annibale, Massimo Marignani, Tu Vinh Luong, Vito Corleto, Andrea Pace, Tetsuhide Ito, David Liewehr, David J. Venzon, Gianfranco Delle Fave, Cesare Bordi & Robert T. Jensen. (2008) A Prospective Study of Gastric Carcinoids and Enterochromaffin-Like Cell Changes in Multiple Endocrine Neoplasia Type 1 and Zollinger-Ellison Syndrome: Identification of Risk Factors. The Journal of Clinical Endocrinology & Metabolism 93:5, pages 1582-1591.
Crossref
Crossref
Yogeshwar Dayal. (2006) Neuroendocrine Tumors of the Gastrointestinal Tract. Pathology Case Reviews 11:6, pages 268-281.
Crossref
Crossref
Andreas Tartaglia, Guida M. Portela-Gomes, Kjell Öberg, Paolo Vezzadini, Maria P. Foschini & Mats Stridsberg. (2006) Chromogranin A in gastric neuroendocrine tumours: an immunohistochemical and biochemical study with region-specific antibodies. Virchows Archiv 448:4, pages 399-406.
Crossref
Crossref
Kurt Borch, Bo Ahrén, Håkan Ahlman, Sture Falkmer, Göran Granérus & Lars Grimelius. (2005) Gastric Carcinoids. Annals of Surgery 242:1, pages 64-73.
Crossref
Crossref
L. Kölby, O. Nilsson & H. Ahlman. (2016) Gastroduodenal Endocrine Tumours. Scandinavian Journal of Surgery 93:4, pages 317-323.
Crossref
Crossref
Jeffrey A. Norton, Marc L. Melcher, Fathia Gibril & Robert T. Jensen. (2004) Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment. Surgery 136:6, pages 1267-1274.
Crossref
Crossref
Jiro Kagawa, Shoji Honda, Masaaki Kodama, Ryugo Sato, Kazunari Murakami & Toshio Fujioka. (2002)
Enterocromaffin‐Like Cell Tumor Induced by
Helicobacter pylori
Infection in Mongolian Gerbils
. Helicobacter 7:6, pages 390-397.
Crossref
Crossref
G. Delle Fave, M. Marignani, V.D. Corleto, S. Angeletti, G. D'Ambra, G. Ferraro, T. D'Adda, C. Azzoni, R.T. Jensen, B. Annibale & C. Bordi. (2002) Progression of gastric enterochromaffin-like cells growth in Zollinger-Ellison syndrome and atrophic body gastritis patients. Digestive and Liver Disease 34:4, pages 270-278.
Crossref
Crossref
Regina Lamberts. (2000) Morphological changes of the human gastric mucosa under long-term proton pump inhibitor therapy and their clinical relevance. Microscopy Research and Technique 48:6, pages 357-366.
Crossref
Crossref
Th�r�se Lehy, Anne-Marie Roucayrol & Michel Mignon. (2000) Histomorphological characteristics of gastric mucosa in patients with Zollinger-Ellison syndrome or autoimmune gastric atrophy: Role of gastrin and atrophying gastritis. Microscopy Research and Technique 48:6, pages 327-338.
Crossref
Crossref
Regina Lamberts & Micheal Gregor. (1999) Die multiple endokrine Neoplasie Typ IClinical manifestations, diagnostic procedures and therapeutic modalities in multiple endocrine neoplasia type I (MEN I) syndrome. Medizinische Klinik 94:8, pages 447-452.
Crossref
Crossref
C. Bordi. (1995) Endocrine Tumours of the Stomach. Pathology - Research and Practice 191:4, pages 373-380.
Crossref
Crossref